Regulation of human life histories: The role of the inflammatory host response

Annals of the New York Academy of Sciences

Volumn 1100, Issue , 2007, Pages 84-97

  Van Bodegom, David ^a   May, Linda ^a   Meij, Hans J ^a   Westendorp, Rudi G J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Aging; Fertility; Human life histories; Innate immunity; r K selection

Indexed keywords

AGING; CONFERENCE PAPER; DEGENERATIVE DISEASE; EVOLUTIONARY ADAPTATION; FERTILITY; GENITAL SYSTEM; HUMAN; HYPOTHESIS; IMMUNE RESPONSE; INFECTION RESISTANCE; INFLAMMATION; INNATE IMMUNITY; LIFE HISTORY; LIFESPAN; MOLECULAR EVOLUTION; NONHUMAN; PROGENY; SURVIVAL; ANIMAL; DROSOPHILA MELANOGASTER; FEMALE; GENE EXPRESSION REGULATION; IMMUNE SYSTEM; LONGEVITY; MALE; MOTHER; PATHOLOGY; POPULATION DYNAMICS; REPRODUCTION; REVIEW; TIME;

AGING; ANIMALS; DROSOPHILA MELANOGASTER; FEMALE; FERTILITY; GENE EXPRESSION REGULATION; HUMANS; IMMUNE SYSTEM; INFLAMMATION; LONGEVITY; MALE; MOTHERS; POPULATION DYNAMICS; REPRODUCTION; TIME FACTORS;

EID: 34249650039     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1395.007     Document Type: Conference Paper

References (80)

1. MACARTHUR, R.H. & E.O. WILSON. 1967. The Theory of Island Biogeography. Princeton University Press. Princeton, NJ.
2. PIANKA, E.R. 1970. R-selection and k-selection. Am. Nat. 104: 592-597.
3. STEARNS, S.C. 1992. The Evolution of Life Histories. Oxford University Press. Oxford.
4. PARTRIDGE, L. & N.H. BARTON. 1993. Optimality, mutation and the evolution of aging. Nature 362: 305-311.
5. SGRO, C.M., G. GEDDES, K. FOWLER & L. PARTRIDGE. 2000. Selection on age at reproduction in Drosophila melanogaster: female mating frequency as a correlated response. Evolution 54: 2152-2155.
6. ROSE, M.R., M.D. DRAPEAU, P.G. YAZDI, et al. 2002. Evolution of late-life mortality in Drosophila melanogaster. Evolution 56: 1982-1991.
7. ZWAAN, B., R. BIJLSMA & R.E. HOEKSTRA. 1995. Direct selection on life-span in Drosophila-melanogaster. Evolution 49: 649-659.
8. ARANTES-OLIVEIRA, N., J. APFELD, A. DILLIN & C. KENYON. 2002. Regulation of life-span by germ-line stem cells in Caenorhabditis elegans. Science 295: 502-505.
9. ARANTES-OLIVEIRA, N., J.R. BERMAN & C. KENYON. 2003. Healthy animals with extreme longevity. Science 302: 611.
10. KIRKWOOD, T.B. 1977. Evolution of ageing. Nature 270: 301-304.
11. WESTENDORP, R.G. 2004. Are we becoming less disposable? EMBO Rep. 5: 2-6.
12. WESTENDORP, R.G. & T.B. KIRKWOOD. 1998. Human longevity at the cost of reproductive success. Nature 396: 743-746.
13. KORPELAINEN, H. 2000. Fitness, reproduction and longevity among European aristocratic and rural Finnish families in the 1700s and 1800s. Proc. Biol. Sci. 267: 1765-1770.
14. THOMAS, F., A.T. TERIOKHIN, F. RENAUD, et al. 2000. Human longevity at the cost of reproductive success: evidence from global data. J. Evol. Biol. 13: 409-414.
15. SMITH, K.R., G.P. MINEAU & L.L. BEAN. 2002. Fertility and post-reproductive longevity. Soc. Biol. 49: 185-205.
16. DOBLHAMMER, G. & J. OEPPEN. 2003. Reproduction and longevity among the British peerage: the effect of frailty and health selection. Proc. Biol. Sci. 270: 1541-1547.
17. VOLAND, E. & C. ENGEL. 1986. Is the postmenopausal-age-at-death variable a fitness-maximizing reproductive strategy? Anthropol. Anz. 44: 19-34.
18. LE BOURG, E., B. THON, J. LEGARE, et al. 1993. Reproductive life of French-Canadians in the 17-18th centuries: a search for a trade-off between early fecundity and longevity. Exp. Gerontol. 28: 217-232.
19. MULLER, H.G., J.M. CHIOU, J.R. CAREY & J.L. WANG. 2002. Fertility and life span: late children enhance female longevity. J. Gerontol. A Biol. Sci. Med. Sci. 57: B202-B206.
20. HELLE, S., P. KAAR & J. JOKELA. 2002. Human longevity and early reproduction in pre-industrial Sami populations. J. Evol. Biol. 15: 803-807.
21. LYCETT, J.E., R.I. DUNBAR & E. VOLAND. 2000. Longevity and the costs of reproduction in a historical human population. Proc. Biol. Sci. 267: 31-35.
22. KORPELAINEN, H. 2000. Fitness, reproduction and longevity among European aristocratic and rural Finnish families in the 1700s and 1800s. Proc. Biol. Sci. 267: 1765-1770.
23. KORPELAINEN, H. 2003. Human life histories and the demographic transition: a case study from Finland, 1870-1949. Am. J. Phys. Anthropol. 120: 384-390.
24. OMRAN, A.R. 2001. The epidemiologic transition. A theory of the epidemiology of population change. 1971. Bull. World Health Organ. 79: 161-170.
25. STEARNS, S.C. 1999. Evolution in Health and Disease. Oxford University Press. Oxford.
26. LE SOUEF, P.N., J. GOLDBLATT & N.R. LYNCH. 2000. Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 356: 242-244.
27. COOKE, G.S. & A.V. HILL. 2001. Genetics of susceptibility to human infectious disease. Nat. Rev. Genet. 2: 967-977.
28. ZINKERNAGEL, R.M. 1996. Immunology taught by viruses. Science 271: 173-178.
29. MEDZHITOV, R., P. PRESTON-HURLBURT & C.A. JANEWAY, JR. 1997. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388: 394-397.
30. MOSMANN, T.R., H. CHERWINSKI, M.W. BOND, et al. 1986. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 136: 2348-2357.
31. MOSMANN, T.R. & S. SAD. 1996. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17: 138-146.
32. KIDD, P. 2003. Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease. Altern. Med. Rev. 8: 223-246.
33. DE CRAEN, A.J., D. POSTHUMA, E.J. REMARQUE, et al. 2005. Heritability estimates of innate immunity: an extended twin study. Genes Immun. 6: 167-170.
34. WESTENDORP, R.G., J.A. LANGERMANS, T.W. HUIZINGA, et al. 1997. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 349: 170-173.
35. VAN DISSEL, J.T., L.P. VAN, R.G. WESTENDORP, et al. 1998. Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351: 950-953.
36. ROBINSON, K., K.R. NEAL, C. HOWARD, et al. 2002. Characterization of humoral and cellular immune responses elicited by meningococcal carriage. Infect. Immun. 70: 1301-1309.
37. FAROUK, S.E., A. DOLO, S. BERECZKY, et al. 2005. Different antibody- and cytokine-mediated responses to Plasmodium falciparum parasite in two sympatric ethnic tribes living in Mali. Microbes Infect. 7: 110-117.
38. SALEM, M.L. 2004. Estrogen, a double-edged sword: modulation of TH1- and TH2-mediated inflammations by differential regulation of TH1/TH2 cytokine production. Curr. Drug Targets Inflamm. Allergy 3: 97-104.
39. AL SHAMMRI, S., P. RAWOOT, F. AZIZIEH, et al. 2004. Th1/Th2 cytokine patterns and clinical profiles during and after pregnancy in women with multiple sclerosis. J. Neurol. Sci. 222: 21-27.
40. HILL, J.A., K. POLGAR & D.J. ANDERSON. 1995. T-helper 1-type immunity to trophoblast in women with recurrent spontaneous abortion. JAMA 273: 1933-1936.
41. MAKHSEED, M., R. RAGHUPATHY, F. AZIZIEH, et al. 2001. Th1 and Th2 cytokine profiles in recurrent aborters with successful pregnancy and with subsequent abortions. Hum. Reprod. 16: 2219-2226.
42. WESTENDORP, R.G., F.M. VAN DUNNE, T.B. KIRKWOOD, et al. 2001. Optimizing human fertility and survival. Nat. Med. 7: 873.
43. GIBSON, A.W., J.C. EDBERG, J. WU, et al. 2001. Novel single nucleotide polymorphisms in the distal IL-10 promoter affect IL-10 production and enhance the risk of systemic lupus erythematosus. J. Immunol. 166: 3915-3922.
44. DOBZHANSKY, T. 1963. Anthropology and the natural-sciences - the problem of human-evolution current. Anthropology 4: 138, 146-148.
45. MEDAWAR, P.B. 1952. An Unsolved Problem of Biology. Lewis. London, UK.
46. WILLIAMS, G.C. 1957. Pleiotropy, natural-selection, and the evolution of senescence. Evolution 11: 398-411.
47. GINALDI, L., M.F. LORETO, M.P. CORSI, et al. 2001. Immunosenescence and infectious diseases. Microbes Infect. 3: 851-857.
48. LIBBY, P., P.M. RIDKER & A. MASERI. 2002. Inflammation and atherosclerosis. Circulation 105: 1135-1143.
49. VAN DEN BIGGELAAR, A.H., T.W. HUIZINGA, A.J. DE CRAEN, et al. 2004. Impaired innate immunity predicts frailty in old age. The Leiden 85-Plus Study. Exp. Gerontol. 39: 1407-1414.
50. VAN DEN BIGGELAAR, A.H., A.J. DE CRAEN, J. GUSSEKLOO, et al. 2004. Inflammation underlying cardiovascular mortality is a late consequence of evolutionary programming. FASEB J. 18: 1022-1024.
51. REMARQUE, E.J., E.L.E.M. BOLLEN, A.W.E. WEVERLING-RIJNSBURGER, et al. 2001. Patients with Alzheimer's disease display a pro-inflammatory phenotype. Exp. Gerontol. 36: 171-176.
52. VAN EXEL, E., A.J.M. DE CRAEN, E.J. REMARQUE, et al. 2003. Interaction of atherosclerosis and inflammation in elderly subjects with poor cognitive function. Neurology 61: 1695-1701.
53. FRANCESCHI, C., M. BONAFE, S. VALENSIN, et al. 2000. Inflammaging. An evolutionary perspective on immunosenescence. Ann. N. Y. Acad. Sci. 908: 244-254.
54. MAGEE, R. 1998. Arterial disease in antiquity. Med. J. Aust. 169: 663-666.
55. OEPPEN, J. & J.W. VAUPEL. 2002. Demography. Broken limits to life expectancy. Science 296: 1029-1031.
56. PADOVANI, J.C., A. PAZIN-FILHO, M.V. SIMOES, et al. 2000. Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb. Res. 100: 263-269.
57. WONG, M.D., M.F. SHAPIRO, W.J. BOSCARDIN & S.L. ETTNER. 2002. Contribution of major diseases to disparities in mortality. N. Engl. J. Med. 347: 1585-1592.
58. ANDERSON, R.N. & B.L. SMITH. 2003. Deaths: leading causes for 2001. Natl. Vital Stat. Rep. 52: 1-85.
59. LOSITO, A., K. KALIDAS, S. SANTONI & S. JEFFERY. 2003. Association of interleukin-6 -174G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int. 64: 616-622.
60. HUTCHINSON, R.G., R.L. WATSON, C.E. DAVIS, et al. 1997. Racial differences in risk factors for atherosclerosis - The ARIC Study. Angiology 48: 279-290.
61. NEATON, J.D., L.H. KULLER, D. WENTWORTH & N.O. BORHANI. 1984. Total and cardiovascular mortality in relation to cigarette-smoking, serum-cholesterol concentration, and diastolic blood-pressure among black and white males followed up for 5 years. Am. Heart J. 108: 759-769.
62. HUTCHINSON, R.G., R.L. WATSON, C.E. DAVIS, et al. 1997. Racial differences in risk factors for atherosclerosis - The ARIC Study. Angiology 48: 279-290.
63. CLARK, L.T. 1999. Primary prevention of cardiovascular disease in high-risk patients: physiologic and demographic risk factor differences between African American and white American populations. Am. J. Med. 107: 22S-24S.
64. ROWLAND, D.T. 1984. Old-age and the demographic-transition population studies-A. J. Demography 38: 73-87.
65. CHATURVEDI, N., P.M. MCKEIGUE & M.G. MARMOT. 1993. Resting and ambulatory blood-pressure differences in Afro-Caribbean and Europeans. Hypertension 22: 90-96.
66. HOFFMANN, S.C., E.M. STANLEY, E.D. COX, et al. 2002. Ethnicity greatly influences cytokine gene polymorphism distribution. Am. J. Transplant. 2: 560-567.
67. NESS, R.B., C.L. HAGGERTY, G. HARGER & R. FERRELL. 2004. Differential distribution of allelic variants in cytokine genes among African Americans and White Americans. Am. J. Epidemiol. 160: 1033-1038.
68. DELANEY, N.L., V. ESQUENAZI, D.P. LUCAS, et al. 2004. TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum. Immunol. 65: 1413-1419.
69. AHERN, J., K.E. PICKETT, S. SELVIN & B. ABRAMS. 2003. Preterm birth among African American and white women: a multilevel analysis of socioeconomic characteristics and cigarette smoking. J. Epidemiol. Community Health 57: 606-611.
70. SIMHAN, H.N., M.A. KROHN, J.M. ROBERTS, et al. 2003. Interleukin-6 promoter -174 polymorphism and spontaneous preterm birth. Am. J. Obstet. Gynecol. 189: 915-918.
71. ROBERTS, A.K., F. MONZON-BORDONABA, P.G. VAN DEERLIN, et al. 1999. Association of polymorphism within the promoter of the tumor necrosis factor alpha gene with increased risk of preterm premature rupture of the fetal membranes. Am. J. Obstet. Gynecol. 180: 1297-1302.
72. DRENOS, F., R.G. WESTENDORP & T.B. KIRKWOOD. 2006. Trade-off mediated effects on the genetics of human survival caused by increasingly benign living conditions. Biogerontology 7: 287-295.
73. UNWIN, N., P. SETEL, S. RASHID, et al. 2001. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda? Bull. World Health Organ. 79: 947-953.
74. BONOW, R.O., L.A. SMAHA, S.C. SMITH, JR., et al. 2002. World Heart Day 2002: the international burden of cardiovascular disease: responding to the emerging global epidemic. Circulation 106: 1602-1605.
75. STRONG, K., C. MATHERS, S. LEEDER & R. BEAGLEHOLE. 2005. Preventing chronic diseases: how many lives can we save? Lancet 366: 1578-1582.
76. YACH, D., C. HAWKES, C.L. GOULD & K.J. HOFMAN. 2004. The global burden of chronic diseases: overcoming impediments to prevention and control. JAMA 291: 2616-2622.
77. NEEL, J.V. 1962. Diabetes mellitus - a thrifty genotype rendered detrimental by progress. Am. J. Hum. Genet. 14: 353-362.
78. BARKER, D.J.P. 1995. Fetal origins of coronary heart-disease. Br. Med. J. 311: 171-174.
79. HOLLIDAY, R. 1995. Understanding Ageing. Cambridge University Press. Cambridge.
80. KIRKWOOD, T.B.L. & S.N. AUSTAD. 2000. Why do we age? Nature 408: 233-238.